Kaiser Permanente’s 2-1-1 pre-exposure prophylaxis (PrEP) program shows event-driven dosing works.
Three women of color—an HIV physician, a public health researcher, and a sexual health advisor—speak about the role of providers in improving services and experiences for women.
For the CDC's proposed updates to PrEP guidelines to be effective, clinicians will need to start talking about sexual health.
During the COVID-19 pandemic, a Chicago hospital offered HIV screenings in the emergency room. Can such measures adequately address gaps along the continuum of care?
Will Oregon’s new bill allowing PrEP without a doctor's prescription improve upon similar laws in California and Colorado?
In sub-Saharan Africa, herbalists and spiritual healers are working closely with researchers to help reduce HIV transmission in rural communities.
While findings from the high-profile AMP studies have excited scientists, they’re only one of a wide range of bNAb avenues currently being pursued.
Beyond the big-picture improvements, a closer look at the data reveals stark racial and geographic disparities in HIV incidence and prevalence.
The findings add to evidence that injectable PrEP could ultimately have greater real-world efficacy than daily oral PrEP in many populations, thanks to better adherence.
New findings from the Antibody-Mediated Prevention (AMP) studies indicate that broadly neutralizing antibodies can work, but several will need to be used in combination.
A new expert consensus statement explores how providers can give birthing parents who are living with HIV the information they need to decide for themselves.